文献速递新发突发、热带与寄生虫病

日本脑炎疫苗及加速接种程序对嵌合黄热病四价登革疫苗免疫原性的影响:美国18-45岁成人II期随机开放标签单中心试验

The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States.
PubMed 文献 · J Infect Dis · 2020-01-01

该II期随机开放标签单中心试验在美国18-45岁成人中比较CYD-TDV按0、6、12月或加速0、2、6月程序接种,以及日本脑炎疫苗同时或先前接种的影响。结果显示加速程序与标准程序的登革病毒血清型特异性中和抗体滴度基本相当,同时接种日本脑炎疫苗未增加总体中和抗体滴度,但先前接种日本脑炎疫苗者CYD-TDV接种后活化CD8+ T细胞增加最明显。

要点

  • CYD-TDV加速0、2、6月程序的血清型特异性中和抗体滴度与0、6、12月程序基本相当。
  • 日本脑炎疫苗与CYD-TDV同时接种未增加总体中和抗体滴度。
  • 先前接种日本脑炎疫苗者CYD-TDV接种后活化CD8+ T细胞增加最明显。

核心结论

  • CYD-TDV加速接种程序(0、2、6月)产生的登革病毒血清型特异性中和抗体滴度与现行0、6、12月程序基本相当。
  • 先前接种日本脑炎疫苗可能对CYD-TDV接种后的早期抗体滴度和活化CD8+ T细胞有益。

研究设计与样本

  • II期、随机、开放标签、单中心试验,在美国18至45岁成人中开展。
  • 比较CYD-TDV按0、6、12月或加速0、2、6月程序接种,以及日本脑炎疫苗同时或先前接种的影响。

主要发现

  • 基于登革病毒血清型特异性中和抗体,加速程序与0、6、12月程序相当。
  • 日本脑炎疫苗与CYD-TDV同时接种未导致总体中和抗体滴度增加。
  • 外周血单个核细胞免疫表型分析显示CYD-TDV接种后活化CD8+ T细胞增加,先前接种日本脑炎疫苗者增加最明显。

临床怎么用

  • 加速0、2、6月程序可作为CYD-TDV现行0、6、12月程序的替代方案,血清型特异性中和抗体滴度基本相当。
  • 先前接种日本脑炎疫苗可能增强CYD-TDV接种后的早期抗体滴度和活化CD8+ T细胞反应。

局限性

  • 单中心、开放标签设计可能影响结果解读。
  • 研究人群为美国18至45岁成人,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dengue is a global health problem requiring an effective, safe dengue vaccine. METHODS: We report the results of a phase II, randomized, open-label, single-center trial in adults aged 18 to 45 years in the United States designed to explore the effects of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine (CYD-TDV, Dengvaxia) when administered on its designated schedule (months 0, 6, and 12) or on an accelerated dosing schedule (months 0, 2, and 6) and/or given before, or concomitantly with, a vaccine against Japanese encephalitis (JE). RESULTS: Based on dengue virus serotype-specific neutralizing antibody (NAb), the accelerated dosing schedule was comparable to the 0, 6, and 12-month schedule. Giving JE vaccine concurrently with CYD-TDV did not result in an increase in overall NAb titers. Immunophenotyping of peripheral blood mononuclear cells revealed an increase in activated CD8+ T cells after CYD-TDV vaccination, a phenomenon that was greatest for the JE vaccine primed. CONCLUSIONS: We conclude that an accelerated dosing schedule of CYD-TDV results in essentially equivalent dengue serotype-specific NAb titers as the currently used schedule, and there may be an early benefit in antibody titers and activated CD8+ T cells by the administration of the JE vaccine before CYD-TDV vaccination.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Glass A, Polhemus M, Wang D, et al. The Effects of Japanese Encephalitis Vaccine and Accelerated Dosing Scheduling on the Immunogenicity of the Chimeric Yellow Fever Derived Tetravalent Dengue Vaccine: A Phase II, Randomized, Open-Label, Single-Center Trial in Adults Aged 18 to 45 Years in the United States. J Infect Dis. 2020. PMID: 31755526. doi:10.1093/infdis/jiz592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。